XCell Therapeutics Inc (373110)

Currency in KRW
1,184
-1(-0.08%)
Closed·
373110 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,1641,218
52 wk Range
1,0904,075
Key Statistics
Bid/Ask
1,184.00 / 1,187.00
Prev. Close
1,185
Open
1,184
Day's Range
1,164-1,218
52 wk Range
1,090-4,075
Volume
42.01K
Average Volume (3m)
479.17K
1-Year Change
-64.5509%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
373110 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-169.38 / --
Revenue / Forecast
1.02B / --
EPS Revisions
Last 90 days

373110 Income Statement

Compare 373110 to Peers and Sector

Metrics to compare
373110
Peers
Sector
Relationship
P/E Ratio
−1.8x−5.2x−0.4x
PEG Ratio
−0.20−0.090.00
Price/Book
3.1x1.7x2.6x
Price / LTM Sales
7.8x5.9x3.1x
Upside (Analyst Target)
-0.0%51.8%
Fair Value Upside
Unlock7.9%7.5%Unlock

Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.01M5.85%1.20B
Public Companies & Retail Investors
16.28M94.15%19.30B
Total
17.29M100.00%20.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Jw Asset Co., Ltd.1.72%297,205352,188
Ignite Innovators Co., Ltd.1.61%279,105330,739

FAQ

What Is the XCell Therapeutics (373110) Stock Price Today?

The XCell Therapeutics stock price today is 1,184 KRW.

What Stock Exchange Does XCell Therapeutics Trade On?

XCell Therapeutics is listed and trades on the KOSDAQ.

What Is the Stock Symbol for XCell Therapeutics?

The stock symbol for XCell Therapeutics is "373110."

What Is the XCell Therapeutics Market Cap?

As of today, XCell Therapeutics market cap is 20.49B KRW.

What Is XCell Therapeutics's Earnings Per Share (TTM)?

The XCell Therapeutics EPS (TTM) is -854.

From a Technical Analysis Perspective, Is 373110 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has XCell Therapeutics Stock Split?

XCell Therapeutics has split 0 times.

What is the current trading status of XCell Therapeutics (373110)?

As of Jul 16, 2026, XCell Therapeutics (373110) is trading at a price of 1,184 KRW, with a previous close of 1,185 KRW. The stock has fluctuated within a day range of 1,164 KRW to 1,218 KRW, while its 52-week range spans from 1,090 KRW to 4,075 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.